Literature DB >> 21362019

LMO4 expression in squamous cell carcinoma of the anterior tongue.

Rhonda A Kwong, Christopher J Scarlett, Larry H Kalish, Ian E Cole, James G Kench, Eleanor Y M Sum, Elizabeth A Musgrove, Susan M Henshall, Geoffrey J Lindeman, Andrew V Biankin, Jane E Visvader, Robert L Sutherland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362019     DOI: 10.1111/j.1365-2559.2011.03765.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  5 in total

1.  LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells.

Authors:  Keshuo Ding; Zhengsheng Wu; Xiaocan Li; Youjing Sheng; Xiaonan Wang; Sheng Tan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  LMO4 is a prognostic marker involved in cell migration and invasion in non-small-cell lung cancer.

Authors:  Wenjun Wang; Sipei Wu; Minzhang Guo; Jianxing He
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 3.  LIM-domain-only proteins in cancer.

Authors:  Jacqueline M Matthews; Krystal Lester; Soumya Joseph; David J Curtis
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716

4.  The LIM-domain only protein 4 contributes to lung epithelial cell proliferation but is not essential for tumor progression.

Authors:  Aliaksei Z Holik; Caitlin E Filby; Julie Pasquet; Kati Viitaniemi; John Ciciulla; Kate D Sutherland; Marie-Liesse Asselin-Labat
Journal:  Respir Res       Date:  2015-06-07

5.  LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer).

Authors:  Elizabeth A Simonik; Ying Cai; Katherine N Kimmelshue; Dana M Brantley-Sieders; Holli A Loomans; Claudia D Andl; Grant M Westlake; Victoria M Youngblood; Jin Chen; Wendell G Yarbrough; Brandee T Brown; Lalitha Nagarajan; Stephen J Brandt
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.